Press release
Leading Element Driving Change in the Myelodysplastic Syndrome Market in 2025: Rising Incidence Of Rare Blood Cancers Boosts Growth In The Myelodysplastic Syndrome (MDS) Market Driver
Myelodysplastic Syndrome Market
The growth of the myelodysplastic syndrome (MDS) market is likely to be fuelled by an increasing number of rare blood cancers. Blood cancers originate from bone marrow, lymph nodes and other blood and immune system components, and have a relatively low incidence rate. The goal of MDS treatment is to control the condition, enhance blood cell production, and manage related symptoms to prevent the development of blood cancer in the bone marrow. For instance, data from the Leukemia and Lymphoma Society indicates that in September 2024, one person is diagnosed with leukemia, lymphoma, or myeloma every three minutes in the US. In 2024, an estimated 187,740 individuals are expected to be diagnosed with these cancers, making up 9.4% of the projected 2,001,140 new cancer cases in the US. Accordingly, this growing prevalence of blood cancer is boosting the MDS market. Myelodysplastic Syndrome Market Driver: The Myelodysplastic Syndrome Market Expected to Expand Due to Projected Increase in Bone Marrow Transplants
Get Your Myelodysplastic Syndrome Market Report Here:
https://www.thebusinessresearchcompany.com/report/myelodysplastic-syndrome-global-market-report
How will the growth rate of the myelodysplastic syndrome market shape industry trends by 2034?
The market for myelodysplastic syndrome has witnessed swift expansion lately. Forecasts suggest a market growth from $2.56 billion in 2024 to $2.85 billion in 2025, manifesting a compound annual growth rate (CAGR) of 11.3%. Factors contributing to this considerable growth during the historic timeframe include increased instances of myelodysplastic syndrome, heightened awareness of treatment options, elevated healthcare expenditure, and government initiatives associated with disease management.
In the coming years, the market size for myelodysplastic syndrome will witness a robust growth, hitting $4.17 billion by 2029 with a compound annual growth rate of 10.0%. Factors contributing to the growth during the prediction period are the aging population, embracing combination therapies, financial injections into hematologic research, and personalized medicine. Forecasted period will see a surge in new and innovative treatments for myelodysplastic syndrome, advancements in diagnostic tools and techniques, clinical trials, and shared research.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12920&type=smp
What trends are poised to drive the future success of the myelodysplastic syndrome market?
Leading firms in the myelodysplastic syndrome (MDS) market are innovating new treatments to solidify their market standing. For example, in August 2023, Bristol Myers Squibb, a pharmaceutical company headquartered in the US, received FDA sanction for Reblozyl (luspatercept-aamt), marking it a pioneering treatment for anemia in ESA-unsophisticated adults with low to intermediate risk myelodysplastic syndromes (MDS) who might require regular RBC transfusions. During the Phase 3 COMMANDS trial, Reblozyl proved more effective than epoetin alfa in achieving RBC transfusion independence and boosting hemoglobin, thus targeting anemia earlier across a more diverse patient base.
Which primary segments of the myelodysplastic syndrome market are driving growth and industry transformations?
The myelodysplastic syndrome market covered in this report is segmented -
1) By Type: Myelodysplastic Syndrome With Unilineage Dysplasia, Myelodysplastic Syndrome With Multilineage Dysplasia, Myelodysplastic Syndrome With Ring Sideroblasts, Other Types
2) By Drug: Azacitidine, Lenalidomide, Decitabine, Deferasirox
3) By Treatment: Supportive Therapy, Growth Factors, Chemotherapy, Stem Cell Transplant, Other Treatments
4) By Route Of Administration: Oral, Injectable, Other Routes Of Administrations
5) By End-Users: Hospitals, Homecare, Specialty Centers, Other End-Users
Subsegments:
1) By Myelodysplastic Syndrome With Unilineage Dysplasia: Type Of Dysplasia, Patient Demographics
2) By Myelodysplastic Syndrome With Multilineage Dysplasia: Severity Of Dysplasia, Patient Demographics
3) By Myelodysplastic Syndrome With Ring Sideroblasts: Percentage Of Ring Sideroblasts, Treatment Options
4) By Other Types: Specific Types, Treatment Options
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12920
Which geographical regions are pioneering growth in the myelodysplastic syndrome market?
North America was the largest region in the myelodysplastic syndrome market in 2024. The regions covered in myelodysplastic syndrome (MDS) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Who are the influential players reshaping the myelodysplastic syndrome market landscape?
Major companies operating in the myelodysplastic syndrome market are Pfizer Inc., Johnson and Johnson Limited, AbbVie Inc., Bayer AG, Novartis AG, Merck & Co., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca Plc., Takeda Pharmaceutical Company Limited, Medtronic PLC, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Otsuka Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Company Ltd., Jazz Pharmaceuticals, Dr. Reddy's Laboratories Ltd., Lupin Limited, BeiGene, Janssen Biotech, Accord Healthcare, Acceleron Pharma Inc.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=12920&type=smp
What Is Covered In The Myelodysplastic Syndrome Global Market Report?
•Market Size Forecast: Examine the myelodysplastic syndrome market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the myelodysplastic syndrome market for a structured understanding.
•Key Players Overview: Analyze major players in the myelodysplastic syndrome market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the myelodysplastic syndrome market.
•Segment Contributions: Evaluate how different segments drive overall growth in the myelodysplastic syndrome market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the myelodysplastic syndrome market.
•Industry Challenges: Identify potential risks and obstacles affecting the myelodysplastic syndrome market.
•Competitive Landscape: Review strategic developments in the myelodysplastic syndrome market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Leading Element Driving Change in the Myelodysplastic Syndrome Market in 2025: Rising Incidence Of Rare Blood Cancers Boosts Growth In The Myelodysplastic Syndrome (MDS) Market Driver here
News-ID: 3914659 • Views: …
More Releases from The Business Research Company
In-Depth Analysis of the Jeanatope Market: Growth Opportunities, Key Trends, and …
What industry-specific factors are fueling the growth of the jeanatope market?
The increase in chronic diseases is predicted to fuel the expansion of the jeanatope market. Chronic diseases, which are prolonged health disorders lasting three months or more, often necessitate continuous treatment and management. Conditions like diabetes, heart disease, and cancer fall under this category. The surge in chronic diseases is linked to aging demographics, lifestyle shifts, and increasing instances of…
Key Trend Reshaping the Inflectra Market in 2025: Innovative Subcutaneous Inflix …
What combination of drivers is leading to accelerated growth in the inflectra market?
The surge in autoimmune diseases, where the immune system wrongly identifies healthy cells as pathogens, causing inflammation and damage to various body tissues and organs, is anticipated to push the growth of the inflectra market. This surge is associated with changes in diet, contact with pollutants, lifestyle habits, and climate change altering the patterns of these diseases. The…
Comprehensive Hyprho-D Market Insights: Forecasting Size, Growth, and Competitiv …
How Are the key drivers contributing to the expansion of the hyprho-d market?
A surge in immunodeficiency disorders is anticipated to boost the expansion of the hyprho-D market. Such conditions involve the immune system's impaired or nonexistent capacity to combat infections and diseases. The rising occurrence of these disorders is due to enhanced diagnostic techniques allowing for earlier and more precise detection, and an aging demographic, which experiences a natural decrease…
Heplisav-B Market Forecast 2025-2034: Evaluating Growth Factors, Segments, and E …
What market dynamics are playing a key role in accelerating the growth of the heplisav-b market?
Anticipated is the acceleration of the heplisav-B market due to the escalating incidence of Hepatitis B infections. Hepatitis B, a liver ailment resulting from the Hepatitis B Virus (HBV), possibly evolves into acute or chronic disorders such as cirrhosis and liver cancer. With low vaccination coverage, transmission within high-risk groups, insufficient awareness, and restricted access…
More Releases for Myelodysplastic
Myelodysplastic Syndrome Market Global Research and Clinical Analysis 2020
Global Myelodysplastic Syndrome Market research report published by market insight reports explores the current outlook in global and key regions from the perspective of Major Players, Countries, Product types and end industries. This report analyzes top players in the global market, and divides the Market into several parameters.
This Myelodysplastic Syndrome Market research report identifies the competitive landscape of industries to understand the competition at International level. This report study describes…
Myelodysplastic Syndrome (MDS) Treatment Market Industry Forecast till 2025
Myelodysplastic (MDS) syndrome is a type of bone marrow disorder, where bone marrow is unable to produce healthy and mature blood cells. The immature blood cells called as blasts, get stored in the bone marrow and blood and obstruct the natural function of the hematological system which results in depletion of healthy red blood cells, platelets, and white blood cells. Myelodysplastic syndrome is usually seen in geriatric population and more…
Myelodysplastic Syndrome Treatment Market Trends and Prospects by 2025
Myelodysplastic Syndrome Treatment Market: Overview
Myelodysplastic syndrome (MDS) is a blood disorder caused due to the production of abnormal blood cells in bone marrow. Bone marrow failure leads to drop in the number of healthy blood cells in the body. In MDS, bone marrow does not produce healthy red blood cells, white blood cells, and/or platelets. Symptoms of MDS in the beginning are no specific than causes of pancytopenia i.e., deficiency…
Myelodysplastic Syndrome Treatment to worth US$ 5.7 Billion by 2025
The Global Myelodysplastic Syndrome Treatment Market was valued at US$ 2,213.2 million in 2017 and is projected to expand at a CAGR of 12.7% during the forecast period (2017–2025), as highlighted in a new report published by Coherent Market Insights. Growing incidence of the bone marrow disorders and cytogenetic abnormalities expected to be the major factor driving growth of the global myelodysplastic syndrome treatment market over the foreseeable future.
Myelodysplastic syndrome…
Myelodysplastic Syndrome Market: Product Innovation to Underscore Lucrative Grow …
Growing prevalence of cancer fuels demand for treatments such as radiation and chemotherapy. Treatment of the cancer has led to increasing prevalence myelodysplastic syndrome globally. The myelodysplastic syndrome is mainly linked to various risk factors such as radiation and chemicals. Market Research Hub research report offers insights on the “Myelodysplastic Syndrome - Epidemiology Forecast to 2025”. This report offers a detailed insight that offer details and important opinions in the Myelodysplastic…
Myelodysplastic Syndrome-Market Insights, Epidemiology and Market Forecast-2025
"The Report Myelodysplastic Syndrome-Market Insights, Epidemiology and Market Forecast-2025 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
DelveInsights Myelodysplastic Syndrome-Market Insights, Epidemiology and Market Forecast-Market Insights, Epidemiology and Market Forecast-2025 report provides an overview of the disease and in depth research related to Myelodysplastic Syndrome-Market Insights, Epidemiology and Market Forecast for the 7MM (United States, Germany, France, Italy, Spain and UK) for…
